ONCOLYTICS BIOTECH INC (ONCY)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch ONCY
See up to 3 months of ONCY. The 7-day demo opens the 1M and 3M ranges and puts ONCY on your watchlist.
Start 7-day demoLatest ONCY insider trades
About ONCOLYTICS BIOTECH INC (ONCY)
The SEC lists ONCOLYTICS BIOTECH INC under CIK 0001129928, in pharmaceutical preparations. It is grouped with Health Care companies on this site.
ONCY Form 4 activity by transaction type, last 90 days
No Form 4 activity for ONCY in the last 90 days.
ONCY insider transactions (Form 4)
2826 Form 4 filings on record, the earliest from Jan 20, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Wayne Pisano - Director | Grant or award | Stock Option | 30,000 | $0.00 | - | |
| Jonathan Rigby - Director | Grant or award | Stock Option | 30,000 | $0.00 | - | |
 Angela Holtham - Director | Grant or award | Stock Option | 30,000 | $0.00 | - | |
| James T. Parsons - Director | Grant or award | Stock Option | 30,000 | $0.00 | - | |
| Kirk Look - Officer | Grant or award | Stock Option | 260,000 | $0.00 | - | |
| Andrew Aromando - Officer | Grant or award | Stock Option | 260,000 | $0.00 | - | |
| Jared Kelly - Officer | Grant or award | Stock Option | 755,000 | $0.00 | - | |
| Patricia S. Andrews - Director | Grant or award | Stock Option | 30,000 | $0.00 | - | |
| Bernd R. Seizinger - Director | Grant or award | Stock Option | 30,000 | $0.00 | - | |
| Allison Hagerman - Officer | Grant or award | Stock Option | 260,000 | $0.00 | - | |
| Deborah Margaret Brown - Director | Grant or award | Stock Option | 30,000 | $0.00 | - | |
| Thomas Charles Heineman - Officer | Grant or award | Stock Option | 260,000 | $0.00 | - | |
| John Bearden McAdory - Officer | Grant or award | Stock Option | 145,000 | $0.00 | - | |
| Stephen C. Glover - Director | Grant or award | Stock Option | 96,000 | $0.00 | - | |
| James T. Parsons - Director | Open-market purchase | Common Shares | 10,000 | $1.03 | $10K | |
| Jared Kelly - Officer | Open-market purchase | Common Shares | 5,050 | $0.96 | $5K | |
| Jared Kelly - Officer | Open-market purchase | Common Shares | 5,600 | $0.84 footnote F1 | $5K | |
| Jared Kelly - Officer | Open-market purchase | Common Shares | 29,500 | $0.84 footnote F1 | $25K | |
| ||||||
| Kirk Look - Officer | Open-market purchase | Common Shares | 12,000 | $0.84 | $10K | |
| Wayne Pisano - Director | Open-market purchase | Common Shares | 30,000 | $0.84 footnote F1 | $25K | |
| ||||||
| Thomas Charles Heineman - Officer | Open-market purchase | Common Shares | 12,132 | $0.83 | $10K | |
| Deborah Margaret Brown - Director | Open-market purchase | Common Shares | 25,000 | $0.85 footnote F1 | $21K | |
| ||||||
| Allison Hagerman - Officer | Open-market purchase | Common Shares | 10,000 | $0.83 | $8K | |
| Bernd R. Seizinger - Director | Open-market purchase | Common Shares | 60,000 | $0.83 | $50K | |
| Bernd R. Seizinger - Director | Open-market purchase | Common Shares | 40,000 | $0.85 | $34K | |
| Andrew Aromando - Officer | Open-market purchase | Common Shares | 29,600 | $0.86 footnote F1 | $25K | |
| ||||||
| Patricia S. Andrews - Director | Open-market purchase | Common Shares | 35,400 | $0.86 footnote F1 | $30K | |
| ||||||
| Bernd R. Seizinger - Director | Open-market purchase | Common Shares | 100,000 | $1.04 footnote F1 | $104K | |
| ||||||
Item 8.01, 9.01
Item 8.01, 9.01
Item 8.01, 9.01
Item 8.01, 9.01
ONCY insider trading FAQ
What is the latest insider trade for ONCY?
ONCOLYTICS BIOTECH INC (ONCY) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-03. The full record for ONCY runs to 26 Form 4 filings, the earliest from 2026-01-20. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ONCY stock?
No insider purchases of ONCY were filed in the last 90 days. 14 purchases are on record for this company.
How many insiders are selling ONCY stock?
No insider sales of ONCY were filed in the last 90 days.
Where can I see ONCY SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ONCY Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Wayne Pisano view on EDGAR
- - Jonathan Rigby view on EDGAR
- - Angela Holtham view on EDGAR
- - James T. Parsons view on EDGAR
- - Kirk Look view on EDGAR
- - Andrew Aromando view on EDGAR
- - Jared Kelly view on EDGAR
- - Patricia S. Andrews view on EDGAR
- - Bernd R. Seizinger view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where ONCY's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ONCY with a 7-day demo
- ONCY on your watchlist
- Every ONCY Form 4 filing on record
- Up to 3 months of ONCY price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
